2011 predictions B+L

[Anonymous]

What are your predictions for B+L for 2011???

 

[Anonymous]

I predict B&L gets hit with a multi hundred million dollar off label law suit that closes down the RX division permanently and finally cuts off the heads of Perry and Kathy.

2011 should be sweet.

 

[Anonymous]

If this happens it will just accelerate bankruptcy restructuring. It's all a gloomy picture.

 

[Anonymous]

I predict B&L gets hit with a multi hundred million dollar off label law suit that closes down the RX division permanently and finally cuts off the heads of Perry and Kathy.

2011 should be sweet.

Flemming will just be waiting on the sidelines with another opportunity for both of them. The rest of us will be left in the dust. They'll skip the legal ramifications as they did at Novartis with Jen Waxman and off they go.

 

[anonymous]

I predict B&L gets hit with a multi hundred million dollar off label law suit that closes down the RX division permanently and finally cuts off the heads of Perry and Kathy.

2011 should be sweet.

Not much has changed has it? Some entities are above the law.

 

[Wow]

Not much has changed has it? Some entities are above the law.

Did you really go through all the posts to find this one in 2011?

Wow....lame. Get a new hobby!

 

[anonymous]

Did you really go through all the posts to find this one in 2011?

Wow....lame. Get a new hobby!

You are avoiding the question. Almost ten years later and nothing has changed. New cast of characters with the same story being told. Same lame molecule with new dosage forms. How is Vyzulta doing? You showed up to the glaucoma party almost 20 years too late. B+L is the same loser company it was in 2011. Is the miracle everyone has been waiting for the new contact lenses? Is that what is going to save B+L? Fraud with the spin-off is most likely going to save this company more than any other single factor. The products and employees cannot seem to turn things around. Pronounce this thing dead already.

B+L has been my hobby for a long time now. I am not going to quit now. FYI, I clicked on the last page of threads, which was page 61, and this was the first one I clicked. This thread was perfectly fitting back in 2011 and is still absolutely relevant today. Trump, Schumer is a moron, force this pile of shit into bankruptcy.

 

[anonymous]

You are avoiding the question. Almost ten years later and nothing has changed. New cast of characters with the same story being told. Same lame molecule with new dosage forms. How is Vyzulta doing? You showed up to the glaucoma party almost 20 years too late. B+L is the same loser company it was in 2011. Is the miracle everyone has been waiting for the new contact lenses? Is that what is going to save B+L? Fraud with the spin-off is most likely going to save this company more than any other single factor. The products and employees cannot seem to turn things around. Pronounce this thing dead already.

B+L has been my hobby for a long time now. I am not going to quit now. FYI, I clicked on the last page of threads, which was page 61, and this was the first one I clicked. This thread was perfectly fitting back in 2011 and is still absolutely relevant today. Trump, Schumer is a moron, force this pile of shit into bankruptcy.

If it has been a hobby for a long time you would know that B+L is truly successful. You can measure it in several ways. Much of our competition has failed (Shire, Novartis, Inspire, Sun, Allergan) or is clinging onto 1-2 products to keep them afloat. Pharma has the #1 spot in several branded categories! Some products are old but they are bringing in revenue since there isn’t much good competition in those particular areas.
Vision Care and Surgical have product launches often and the industry is responding to them very favorably. Lastly, the Commercial division is literally printing money with all the gains from Lumify and Preservision. Honestly, I think you need to do your research!

The leadership of Kobe and Perry was a joke and that is why so many left years ago. Turnover now is incredibly low with them gone.

 

[anonymous]

If it has been a hobby for a long time you would know that B+L is truly successful. You can measure it in several ways. Much of our competition has failed (Shire, Novartis, Inspire, Sun, Allergan) or is clinging onto 1-2 products to keep them afloat. Pharma has the #1 spot in several branded categories! Some products are old but they are bringing in revenue since there isn’t much good competition in those particular areas.
Vision Care and Surgical have product launches often and the industry is responding to them very favorably. Lastly, the Commercial division is literally printing money with all the gains from Lumify and Preservision. Honestly, I think you need to do your research!

The leadership of Kobe and Perry was a joke and that is why so many left years ago. Turnover now is incredibly low with them gone.

First, you need to do your own research. The first question you should ask yourself is, "what exactly is B+L selling?" Second, I would not call 20ish million in sales per quarter "printing money" for a company this size. Lastly, you did not fully address the original post from 2011.

I do have a question based on your response. Which B+L products hold the #1 position in pharma?

As for Allergan, could Valient's hostile attempt to take them over played a significant role to their current state? As for the other companies you mentioned, did they actually fail? If yes, did they deserve to fail? If the companies you mentioned deserved to fail, then should B+L have also failed a long time ago?

 

[anonymous]

First, you need to do your own research. The first question you should ask yourself is, "what exactly is B+L selling?" Second, I would not call 20ish million in sales per quarter "printing money" for a company this size. Lastly, you did not fully address the original post from 2011.

I do have a question based on your response. Which B+L products hold the #1 position in pharma?

As for Allergan, could Valient's hostile attempt to take them over played a significant role to their current state? As for the other companies you mentioned, did they actually fail? If yes, did they deserve to fail? If the companies you mentioned deserved to fail, then should B+L have also failed a long time ago?

 

[anonymous]

First, you need to do your own research. The first question you should ask yourself is, "what exactly is B+L selling?" Second, I would not call 20ish million in sales per quarter "printing money" for a company this size. Lastly, you did not fully address the original post from 2011.

I do have a question based on your response. Which B+L products hold the #1 position in pharma?

As for Allergan, could Valient's hostile attempt to take them over played a significant role to their current state? As for the other companies you mentioned, did they actually fail? If yes, did they deserve to fail? If the companies you mentioned deserved to fail, then should B+L have also failed a long time ago?

 

[anonymous]

First, you need to do your own research. The first question you should ask yourself is, "what exactly is B+L selling?" Second, I would not call 20ish million in sales per quarter "printing money" for a company this size. Lastly, you did not fully address the original post from 2011.

I do have a question based on your response. Which B+L products hold the #1 position in pharma?

As for Allergan, could Valient's hostile attempt to take them over played a significant role to their current state? As for the other companies you mentioned, did they actually fail? If yes, did they deserve to fail? If the companies you mentioned deserved to fail, then should B+L have also failed a long time ago?

As I said earlier do you research. If you knew the industry you would know what happened to all these companies. Additionally you would know the leaders and the reason why they failed. Lastly, why don’t you review the investor slide deck for the company and you’ll see the 300 million dollars plus the commercial division did vs the 20 million you claim they had

You don’t know the company, competition, our #1 brands, or the difference in leadership/culture since KK and PS left. You can view their ineptitude by following where they went and the failure which followed.

I hate to have a battle of wits vs an unarmed person.

 

[anonymous]

As I said earlier do you research. If you knew the industry you would know what happened to all these companies. Additionally you would know the leaders and the reason why they failed. Lastly, why don’t you review the investor slide deck for the company and you’ll see the 300 million dollars plus the commercial division did vs the 20 million you claim they had

You don’t know the company, competition, our #1 brands, or the difference in leadership/culture since KK and PS left. You can view their ineptitude by following where they went and the failure which followed.

I hate to have a battle of wits vs an unarmed person.

I should have been more clear about Lumify earning 20ish million per quarter. In Q2 2020 the investor slide states 15 million. That is not an impressive figure. Is Lumify a new innovative molecule? No, it is Brimonidine.

Vyzulta GoodRX price $208. Generic Xalatan GoodRX price $7. Is Vyzulta that much better to justify the significant price difference?

Eye vitamins? Which eye are they going to help?

Is the B+L sales team marketing Lotemax for surgery as indicated or off-label for dry eyes?

If we recalculated B+L's legitimate sales from their fraudulent sales, then we would have a much smaller number.

 

[anonymous]

I should have been more clear about Lumify earning 20ish million per quarter. In Q2 2020 the investor slide states 15 million. That is not an impressive figure. Is Lumify a new innovative molecule? No, it is Brimonidine.

Vyzulta GoodRX price $208. Generic Xalatan GoodRX price $7. Is Vyzulta that much better to justify the significant price difference?

Eye vitamins? Which eye are they going to help?

Is the B+L sales team marketing Lotemax for surgery as indicated or off-label for dry eyes?

If we recalculated B+L's legitimate sales from their fraudulent sales, then we would have a much smaller number.

OMG you must be the most clueless person ever! It is called SCIENCE and Managed Care.....look them up!

Vyzulta better than latanoprost....YES, too many reasons and clinical studies to back that up....managed care brings the copays way down....coupons even further! Patients only pays a fraction of the price you quoted.

Eye Vitamins.....we offer several which follow AREDS recommendations or offer other benefits (OcuVite, Preservision). Also...saying ”which eye?”.....that’s like asking which part of the body a daily PO vitamin goes to. They offer benefits to help keep eyes healthy or prevent progression of various eye diseases.

Lotemax—-the last 2 formulations have surgical only indications, the predecessor did have ocular surface treatment claims. So your question about “off label” isn’t really appropriate as there is a viable option. The current sales aids for the newer versions are 100% geared for their indications and are entirely surgical in nature—there is no intentional marketing for Dry Eye.

What you probably don’t realize is doctors can prescribe whatever they want. So if a doc gives a newer version for dry eye....it’s because the doctor WANTS it for whatever reason. Your issue is really with the doctor..not with B+L. There is no way to call this fraudulent since the doctor is making a clinically based decision. Compliance is everywhere from sales aides, to samples, to expenses—when you go through what our parent company (Valeant) created, the result is a squeaky clean environment moving forward.

Sit down with a doctor for the questions you want answers to. You will hear many off them prescribing off-label because they want to, AND EVEN WORSE doctors are selling non-FDA approved compounded drugs to patients for profit! These sales are to patients who do not require a compounded drug—-nothing special or any clinical predisposition requiring a compound—-just profit for the doctor. Research those companies for your “Fraudulent sales”.

And NO they don’t disclose this to patients—they disclose when they are owners in surgery centers, why don’t they disclose they make $$$ from this??

It seems like you need some basic industry knowledge and sitting down with a doctor would help.

I’m done. I won’t be responding anymore. This isn’t complicated.....and you are searching for something that isn’t there or you don’t comprehend. the science is there, you didn’t do the research for your answer. The costs and product claims are clear, but you don’t want to accept them.
It’s like breaking down the alphabet to a toddler. You are stuck on the letter “A” when everyone has learned it all.

Bye!

 

[anonymous]

OMG you must be the most clueless person ever! It is called SCIENCE and Managed Care.....look them up!

Vyzulta better than latanoprost....YES, too many reasons and clinical studies to back that up....managed care brings the copays way down....coupons even further! Patients only pays a fraction of the price you quoted.

Eye Vitamins.....we offer several which follow AREDS recommendations or offer other benefits (OcuVite, Preservision). Also...saying ”which eye?”.....that’s like asking which part of the body a daily PO vitamin goes to. They offer benefits to help keep eyes healthy or prevent progression of various eye diseases.

Lotemax—-the last 2 formulations have surgical only indications, the predecessor did have ocular surface treatment claims. So your question about “off label” isn’t really appropriate as there is a viable option. The current sales aids for the newer versions are 100% geared for their indications and are entirely surgical in nature—there is no intentional marketing for Dry Eye.

What you probably don’t realize is doctors can prescribe whatever they want. So if a doc gives a newer version for dry eye....it’s because the doctor WANTS it for whatever reason. Your issue is really with the doctor..not with B+L. There is no way to call this fraudulent since the doctor is making a clinically based decision. Compliance is everywhere from sales aides, to samples, to expenses—when you go through what our parent company (Valeant) created, the result is a squeaky clean environment moving forward.

Sit down with a doctor for the questions you want answers to. You will hear many off them prescribing off-label because they want to, AND EVEN WORSE doctors are selling non-FDA approved compounded drugs to patients for profit! These sales are to patients who do not require a compounded drug—-nothing special or any clinical predisposition requiring a compound—-just profit for the doctor. Research those companies for your “Fraudulent sales”.

And NO they don’t disclose this to patients—they disclose when they are owners in surgery centers, why don’t they disclose they make $$$ from this??

It seems like you need some basic industry knowledge and sitting down with a doctor would help.

I’m done. I won’t be responding anymore. This isn’t complicated.....and you are searching for something that isn’t there or you don’t comprehend. the science is there, you didn’t do the research for your answer. The costs and product claims are clear, but you don’t want to accept them.
It’s like breaking down the alphabet to a toddler. You are stuck on the letter “A” when everyone has learned it all.

Bye!

You are wrong about almost everything that you typed. The industry knowledge that you believe you possess is actually ignorance or a lack of industry knowledge. You are a koolaid drinker. You have an inability to think outside the box. What your are told by your superiors is the truth, even if it is false and misleading. You are a me too and a yes sir/ma'am individual. Do not take it personally, you are not the only one, most of the people at B+L think exactly like you think.

 

[anonymous]

OMG you must be the most clueless person ever! It is called SCIENCE and Managed Care.....look them up!

Vyzulta better than latanoprost....YES, too many reasons and clinical studies to back that up....managed care brings the copays way down....coupons even further! Patients only pays a fraction of the price you quoted.

Eye Vitamins.....we offer several which follow AREDS recommendations or offer other benefits (OcuVite, Preservision). Also...saying ”which eye?”.....that’s like asking which part of the body a daily PO vitamin goes to. They offer benefits to help keep eyes healthy or prevent progression of various eye diseases.

Lotemax—-the last 2 formulations have surgical only indications, the predecessor did have ocular surface treatment claims. So your question about “off label” isn’t really appropriate as there is a viable option. The current sales aids for the newer versions are 100% geared for their indications and are entirely surgical in nature—there is no intentional marketing for Dry Eye.

What you probably don’t realize is doctors can prescribe whatever they want. So if a doc gives a newer version for dry eye....it’s because the doctor WANTS it for whatever reason. Your issue is really with the doctor..not with B+L. There is no way to call this fraudulent since the doctor is making a clinically based decision. Compliance is everywhere from sales aides, to samples, to expenses—when you go through what our parent company (Valeant) created, the result is a squeaky clean environment moving forward.

Sit down with a doctor for the questions you want answers to. You will hear many off them prescribing off-label because they want to, AND EVEN WORSE doctors are selling non-FDA approved compounded drugs to patients for profit! These sales are to patients who do not require a compounded drug—-nothing special or any clinical predisposition requiring a compound—-just profit for the doctor. Research those companies for your “Fraudulent sales”.

And NO they don’t disclose this to patients—they disclose when they are owners in surgery centers, why don’t they disclose they make $$$ from this??

It seems like you need some basic industry knowledge and sitting down with a doctor would help.

I’m done. I won’t be responding anymore. This isn’t complicated.....and you are searching for something that isn’t there or you don’t comprehend. the science is there, you didn’t do the research for your answer. The costs and product claims are clear, but you don’t want to accept them.
It’s like breaking down the alphabet to a toddler. You are stuck on the letter “A” when everyone has learned it all.

Bye!

This post was a Mic Drop moment! Straight up spitting facts on the OP who is trying to stir sh*t up!!

 

[anonymous]

You are wrong about almost everything that you typed. The industry knowledge that you believe you possess is actually ignorance or a lack of industry knowledge. You are a koolaid drinker. You have an inability to think outside the box. What your are told by your superiors is the truth, even if it is false and misleading. You are a me too and a yes sir/ma'am individual. Do not take it personally, you are not the only one, most of the people at B+L think exactly like you think.

This was weak.....You got told!!

 

[anonymous]

This was weak.....You got told!!

Hot tub has a definition according to a number of different dictionaries. Dietary supplement has a definition according to the FDA. Eye vitamin(s) is not defined by any dictionary nor the FDA.

The topic of Vyzulta v. Generic Xalatan is subjective. Does the cost associated with every millimeter of mercury really matter? I am a cash paying customer living within a budget, so for me, cost does matter. Even if I had prescription coverage, does the cost of every millimeter of mercury really matter? At 28 days I MAY experience an additional 4.8% reduction in IOP if I am prescribed Vyzulta rather than generic Xalatan. What can I reasonably expect after five years of using Vyzulta rather than generic Xalatan? Twenty-eight days means nothing to me in terms of cost and/or results. Five years means a lot in terms of cost and/or results.

Your turn.

 

[anonymous]

How about a Zygote Vitamin and Mineral Supplement?

 

[anonymous]

Hot tub has a definition according to a number of different dictionaries. Dietary supplement has a definition according to the FDA. Eye vitamin(s) is not defined by any dictionary nor the FDA.

The topic of Vyzulta v. Generic Xalatan is subjective. Does the cost associated with every millimeter of mercury really matter? I am a cash paying customer living within a budget, so for me, cost does matter. Even if I had prescription coverage, does the cost of every millimeter of mercury really matter? At 28 days I MAY experience an additional 4.8% reduction in IOP if I am prescribed Vyzulta rather than generic Xalatan. What can I reasonably expect after five years of using Vyzulta rather than generic Xalatan? Twenty-eight days means nothing to me in terms of cost and/or results. Five years means a lot in terms of cost and/or results.

Your turn.